US biopharmaceutical finance and the sustainability of the biotech business model
Author:
Publisher
Elsevier BV
Subject
Management of Technology and Innovation,Management Science and Operations Research,Strategy and Management
Reference91 articles.
1. Information asymmetry, R&D, and insider gains;Aboody;The Journal of Finance,2000
2. Estimating the cost of new drug development: is it really $802 Million?;Adams;Health Affairs – MarketWatch,2006
3. Biotechnology as an intellectual property;Adler;Science,1984
4. The changing technology of technological change: general and abstract knowledge and the division of innovative labour;Arora;Research Policy,1994
5. Standing on the shoulders of midgets: the U.S small business innovation research program (SBIR);Audretsch;Small Business Economics,2003
Cited by 193 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Do high drug prices fund pharmaceutical innovation?;Healthcare Management Forum;2024-08-12
2. Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem;Humanities and Social Sciences Communications;2024-07-20
3. The company of the future: Integrating sustainability, growth, and profitability in contemporary business models;Development and Sustainability in Economics and Finance;2024-06
4. CORPORATE FINANCIALIZATION AND GREEN TECHNOLOGY INNOVATION: EVIDENCE FROM CHINESE-LISTED MANUFACTURING COMPANIES;The Singapore Economic Review;2024-05-14
5. High‐Tech Industry;International Encyclopedia of Geography;2024-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3